Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

TAMIFLU (oseltamivir phosphate) 30, 45 and 75 mg capsules and TAMIFLU (oseltamivir phosphate) 6 mg/mL powder for oral suspension
Company: Hoffmann-La Roche, Inc.
Application No.: 021246Orig1s045 and 021087Orig1s062
Approval Date: 12/21/2012

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.


Date created: April 8, 2013

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.